FORM 4 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). |
1. Name and Address of Reporting Person*
(Street)
|
2. Issuer Name and Ticker or Trading Symbol
TARGETED GENETICS CORP /WA/ [ TGEN ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
||||||||||||||||||||||||
3. Date of Earliest Transaction
(Month/Day/Year) 08/09/2000 | ||||||||||||||||||||||||||
4. If Amendment, Date of Original Filed
(Month/Day/Year) |
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
1. Title of Security (Instr. 3) | 2. Transaction Date (Month/Day/Year) | 2A. Deemed Execution Date, if any (Month/Day/Year) | 3. Transaction Code (Instr. 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) | 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price | ||||||
Common Stock | 08/09/2000 | P | 382,739 | A | $13.064 | 2,531,638 | I(1) | N/A(1) | ||
Common Stock | 09/02/2003 | J(2) | 3,577,879 | A | $2.09(2) | 6,109,517 | I(1) | N/A(1) | ||
Common Stock | 09/02/2003 | J(2) | 487,248 | A | $1.95(2) | 6,596,765 | I(1) | N/A(1) | ||
Common Stock | 09/02/2003 | J(2) | 101,439 | A | $1.88(2) | 6,698,204 | I(1) | N/A(1) | ||
Common Stock | 09/02/2003 | J(2) | 107,044 | A | $1.19(2) | 6,805,248 | I(1) | N/A(1) | ||
Common Stock | 09/02/2003 | J(2) | 124,630 | A | $0.96(2) | 6,929,878 | I(1) | N/A(1) | ||
Common Stock | 09/02/2003 | J(2) | 217,549 | A | $0.83(2) | 7,147,427 | I(1) | N/A(1) | ||
Common Stock | 09/02/2003 | J(2) | 87,922 | A | $0.65(2) | 7,235,349 | I(1) | N/A(1) | ||
Common Stock | 09/02/2003 | J(2) | 221,757 | A | $0.57(2) | 7,457,106 | I(1) | N/A(1) | ||
Common Stock | 09/02/2003 | J(2) | 277,775 | A | $0.49(2) | 7,734,882 | I(1) | N/A(1) |
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. Title of Derivative Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Convertible Promissory Note(3) | $6.11(4) | 09/26/2001 | P | $2,000,000 | 11/05/2003 | (5) | Common Stock | 327,399 | $2,000,000 | $2,000,000 | I(1) | N/A | |||
Convertible Promissory Note(6) | $3.7(4) | 03/26/2002 | J(4) | $120,000 | 11/05/2003 | (5) | Common Stock | 32,432 | $120,000 | $2,120,000 | I(1) | N/A | |||
Convertible Promissory Note(3) | $3.78(4) | 04/25/2002 | P | $2,000,000 | 11/05/2003 | (5) | Common Stock | 529,801 | $2,000,000 | $4,120,000 | I(1) | N/A | |||
Convertible Promissory Note(3) | $2.48(4) | 06/28/2002 | P | $3,000,000 | 11/05/2003 | (5) | Common Stock | 1,211,509 | $3,000,000 | $7,120,000 | I(1) | N/A | |||
Convertible Promissory Note(3) | $1.95(4) | 08/09/2002 | P | $950,000 | 11/05/2003 | (5) | Common Stock | 487,248 | $950,000 | $8,070,000 | I(1) | N/A | |||
Convertible Promissory Note(6) | $1.19(4) | 09/26/2002 | J(4) | $127,200 | 11/05/2003 | (5) | Common Stock | 107,044 | $127,200 | $8,197,200 | I(1) | N/A | |||
Convertible Promissory Note(6) | $0.96(4) | 10/25/2002 | J(4) | $120,000 | 11/05/2003 | (5) | Common Stock | 124,630 | $120,000 | $8,317,000 | I(1) | N/A | |||
Convertible Promissory Note(6) | $0.83(4) | 12/28/2002 | J(4) | $180,000 | 11/05/2003 | (5) | Common Stock | 217,549 | $180,000 | $8,497,200 | I(1) | N/A | |||
Convertible Promissory Note(6) | $0.65(4) | 02/09/2003 | J(4) | $57,000 | 11/05/2003 | (5) | Common Stock | 87,922 | $57,000 | $8,554,200 | I(1) | N/A | |||
Convertible Promissory Note(6) | $0.49(4) | 03/26/2003 | J(4) | $134,832 | 11/05/2003 | (5) | Common Stock | 277,775 | $134,832 | $8,689,032 | I(1) | N/A | |||
Convertible Promissory Note(6) | $1.88(4) | 06/28/2003 | J(4) | $190,800 | 11/05/2003 | (5) | Common Stock | 101,439 | $190,800 | $9,007,032 | I(1) | N/A | |||
Convertible Promissory Note(6) | $2.8(4) | 08/09/2003 | J(4) | $63,420 | 11/05/2003 | (5) | Common Stock | 22,650 | $63,420 | $9,070,452 | I(1) | N/A | |||
Convertible Promissory Note(6) | $2.09(4) | 09/02/2003 | J(4) | $302,934 | 11/05/2003 | (5) | Common Stock | 144,779 | $302,934 | $9,373,386 | I(1) | N/A | |||
Convertible Promissory Note | $6.11 | 09/02/2003 | J(7) | $2,000,000 | 11/05/2003 | (5) | Common Stock | 327,399 | $2,000,000 | $7,373,386 | I(1) | N/A | |||
Convertible Promissory Note | $3.7 | 09/02/2003 | J(7) | $120,000 | 11/05/2003 | (5) | Common Stock | 32,432 | $120,000 | $7,253,386 | I(1) | N/A | |||
Convertible Promissory Note | $3.78 | 09/02/2003 | J(7) | $2,000,000 | 11/05/2003 | (5) | Common Stock | 529,801 | $2,000,000 | $5,253,386 | I(1) | N/A | |||
Convertible Promissory Note | $2.48 | 09/02/2003 | J(7) | $3,000,000 | 11/05/2003 | (5) | Common Stock | 1,211,509 | $3,000,000 | $2,253,386 | I(1) | N/A | |||
Convertible Promissory Note | $1.95 | 09/02/2003 | J(7) | $950,000 | 11/05/2003 | (5) | Common Stock | 487,248 | $950,000 | $1,303,386 | I(1) | N/A | |||
Convertible Promissory Note | $1.19 | 09/02/2003 | J(7) | $127,200 | 11/05/2003 | (5) | Common Stock | 107,044 | $127,200 | $1,176,186 | I(1) | N/A | |||
Convertible Promissory Note | $0.96 | 09/02/2003 | J(7) | $120,000 | 11/05/2003 | (5) | Common Stock | 124,630 | $120,000 | $1,056,186 | I(1) | N/A | |||
Convertible Promissory Note | $0.83 | 09/02/2003 | J(7) | $180,000 | 11/05/2003 | (5) | Common Stock | 217,549 | $180,000 | $876,186 | I(1) | N/A | |||
Convertible Promissory Note | $0.65 | 09/02/2003 | J(7) | $57,000 | 11/05/2003 | (5) | Common Stock | 87,922 | $57,000 | $819,186 | I(1) | N/A | |||
Convertible Promissory Note | $0.49 | 09/02/2003 | J(7) | $134,832 | 11/05/2003 | (5) | Common Stock | 277,775 | $134,832 | $684,354 | I(1) | N/A | |||
Convertible Promissory Note | $0.57 | 09/02/2003 | J(7) | $127,200 | 11/05/2003 | (5) | Common Stock | 221,757 | $127,200 | $557,154 | I(1) | N/A | |||
Convertible Promissory Note | $1.88 | 09/02/2003 | J(7) | $190,800 | 11/05/2003 | (5) | Common Stock | 101,439 | $190,800 | $366,354 | I(1) | N/A | |||
Convertible Promissory Note | $2.8 | 09/02/2003 | J(7) | $63,420 | 11/05/2003 | (5) | Common Stock | 22,650 | $63,420 | $302,934 | I(1) | N/A | |||
Convertible Promissory Note | $2.09 | 09/02/2003 | J(7) | $302,934 | 11/05/2003 | (5) | Common Stock | 144,779 | $302,934 | $0 | I(1) | N/A | |||
Series B Convertible Exchangeable Preferred Stock | $3.32 | 09/02/2003(8) | J(8) | 0(8) | 11/05/2003 | (5) | Common Stock | 0(8) | $0(8) | $0(8) | I(1) | N/A | |||
Convertible Promissory Note(6) | $0.57(4) | 04/25/2003 | J(4) | $127,200 | 11/05/2003 | (5) | Common Stock | 221,757 | $127,200 | $8,816,232 | I(1) | N/A |
1. Name and Address of Reporting Person*
(Street)
Relationship of Reporting Person(s) to Issuer
| ||||||||||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
Relationship of Reporting Person(s) to Issuer
|
Explanation of Responses: |
1. These securities are or were beneficially owned indirectly by Elan Corporation, plc ("Elan") and directly by its wholly-owned subsidiary, Elan International Services, Ltd. ("EIS"). The Convertible Promissory Note was owned directly by Elan Pharma International Limited, another wholly-owned subsidiary of Elan, but the right to convert the Convertible Promissory Notes and receive Common Stock upon conversion was owned by EIS. |
2. The reporting person received the shares of common stock as a prepayment by the Issuer of principal and accrued interest in respect of a Convertible Promissory Note, at a price per share, in respect of each tranche, equal to the lesser of (i) $2.09 (the average of the closing price of the Common Stock for the 60 trading days ending two business days prior to the date of repayment) and (ii) the fixed conversion price for conversion of such tranche at the option of the holder of the conversion right. |
3. Each a drawdown of a tranche of the Convertible Promissory Note. |
4. Price at which the Convertible Promissory Note was convertible at the option of the holder of the conversion right. In addition, the Convertible Promissory Note was prepayable at the option of the Issuer on a per tranche basis by the issuance to the holder of the conversion right of a number of shares of Common Stock equal to the outstanding principal amount of such tranche and any and all accrued and unpaid interest thereon divided by the lesser of (1) the price equal to the average of the closing price of the Common Stock for the 60 trading days prior to the date of repayment and (2) the conversion price for conversion at the option of the holder of the conversion right. |
5. The Convertible Promissory Note was convertible until it was repaid in full. The stated maturity of the Convertible Promissory Note was July 21, 2005. However, it was repaid in full by the Issuer, effective September 2, 2003. |
6. Represents interest on the Convertible Promissory Note that was capitalized and added to the principal amount. |
7. The principal and accrued interest in respect of the Convertible Promissory Note was prepaid by the Issuer by the issuance of a number of shares of Common Stock equal to, for each tranche, the outstanding principal amount plus accrued interest divided by the lesser of (1) $2.09 and (2) the conversion price for conversion at the option of the holder of the conversion right. |
8. The 12,015 shares of Series B Convertible Exchangeable Preferred Stock accrues dividends equal to 7.0% per annum of $1,000.00 per share plus accrued dividends thereon, compounded on a semi-annual basis until July 21, 2005, payable by the issuance of additional shares of Common Stock upon conversion of the Series B Convertible Exchangeable Preferred Stock at a conversion price per share of $3.32, subject to customary antidilution adjustments. As of November 5, 2003, accrued dividends would be convertible into 1,245,215 shares of Common Stock. If the Series B Convertible Exchangeable Preferred Stock is held by the reporting person until at least July 21, 2005, the date on which dividends cease to accrue, accrued dividends will be convertible into 1,851,570 shares of Common Stock. |
Remarks: |
Name: Shane M. Cooke Title: Chief Financial Officer ELAN CORPORATION,PLC Exhibit List Exhibit 99-Joint Filer Information |
/s/ Shane M. Cooke | 11/05/2003 | |
** Signature of Reporting Person | Date | |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v). | ||
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |